​

Funding Round

Series C - LaNova Medicines

Series C - LaNova Medicines

Investment Firm

Overview

LaNova Medicines is a clinical-stage innovative drug research and development company.

Announced Date

Jul 01, 2024

Funding Type

Series C

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

N/A

Participant Investors

1

Investor Name
Participant InvestorQiming Venture Partners

Round Details and Background

LaNova Medicines raised $43754042 on 2024-07-01 in Series C

LaNova Medicines is a clinical-stage innovative drug research and development company.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 01, 2020
Seed Round - LaNova Medicines
1-undefined
Jul 01, 2020
Series A - LaNova Medicines
4-undefined
Jan 01, 2021
Series A - LaNova Medicines
4-86.5M
Jul 01, 2024
Series C - LaNova Medicines
1-43.8M

Recent Activity

There is no recent news or activity for this profile.